Rolf Westerberg

Rolf Westerberg is an accomplished Project and Portfolio Manager at Orexo AB publ since January 2022, with extensive experience in clinical development and toxicology. Prior roles include Director of Clinical Development and Global Project Manager at Affibody AB, and Project Manager at Moberg Pharma, where responsibilities included overseeing pre-clinical and clinical projects in dermatology. At AstraZeneca, Rolf held several key positions, notably as Atherosclerosis and Cardiovascular Disease Lead Toxicologist and Study Director, contributing to regulatory studies and guiding teams in China. Rolf's career began at Roche as a post-doctoral researcher focused on obesity and diabetes. Rolf holds a Ph.D. in Physiology from Stockholm University, along with multiple advanced degrees in relevant fields.